Summary

The telehealth and telemedicine market is projected to reach USD 198.9 billion by 2031 from USD 118.8 billion in 2026, at a CAGR of 10.9% from 2026 to 2031. The market is witnessing strong expansion, primarily driven by the growing geriatric and medically underserved populations, particularly in rural and remote areas, the rising prevalence of chronic diseases, and the increasing need for accessible healthcare amid persistent shortages of physicians and other healthcare professionals. In addition, advancements in telecommunications infrastructure, wider smartphone and internet penetration, cloud-based healthcare platforms, and the expanding adoption of remote patient monitoring (RPM) systems are further supporting market growth. The growing integration of AI-enabled medical devices, digital health platforms, and virtual consultations is also improving the scalability and efficiency of remote healthcare delivery. Healthcare providers, payers, and technology companies are increasingly adopting telehealth solutions to improve access to care, support continuous disease management, reduce unnecessary hospital visits, and enable more personalized patient engagement. However, regulatory variations across regions, growing concerns surrounding fraud and abuse within healthcare systems, data privacy and cybersecurity risks, interoperability challenges, and behavioral reluctance to adopt new technologies are expected to restrain market growth during the forecast period.

The patients segment is emerging as the fastest-growing end user in the telehealth and telemedicine market.

By end user, the patients segment is projected to register the fastest growth during the forecast period, supported by increasing consumer adoption of virtual consultations, remote patient monitoring, and digitally enabled healthcare services. Growing demand for convenient and accessible care, particularly among elderly individuals, patients with chronic conditions, and populations in rural or underserved areas, is encouraging more patients to directly engage with telehealth platforms. The increasing availability of smartphones, connected health devices, and user-friendly digital healthcare applications is further facilitating patient participation in remote care. In addition, the growing acceptance of virtual visits for primary care, follow-up consultations, behavioral health, and chronic disease management is expected to accelerate the expansion of the patients segment through 2031.

By component, the software segment accounted for the largest share of the telehealth and telemedicine market in 2025.

By component, the software segment is projected to account for the largest market share and register the fastest growth during the forecast period. The increasing adoption of telehealth platforms, virtual consultation applications, remote patient monitoring software, electronic health record integration, and digital care management solutions primarily drives this dominance. Healthcare providers are increasingly deploying software platforms to facilitate virtual consultations, streamline clinical workflows, enable real-time patient monitoring, and improve communication between patients and healthcare professionals. In addition, advancements in artificial intelligence, cloud computing, data analytics, and interoperability are enhancing the functionality and scalability of telehealth software solutions. The growing demand for integrated, user-friendly, and secure digital healthcare platforms is expected to further support the expansion of the software segment through 2031.

Asia Pacific is expected to register the highest growth during the forecast period.

By region, Asia Pacific (APAC) is projected to register the fastest growth during the forecast period, driven by the expanding healthcare needs of its large and rapidly aging population, rising prevalence of chronic diseases, and significant disparities in healthcare access across urban and rural areas. Increasing investments in digital healthcare infrastructure, improving internet and smartphone penetration, and the growing adoption of virtual consultations and remote patient monitoring are further supporting market expansion across the region. In addition, government initiatives promoting digital health, the development of telemedicine infrastructure, and increasing healthcare technology investments in countries such as China, India, Japan, South Korea, and Australia are creating favorable conditions for market growth. The region's large patient population and growing demand for affordable and accessible healthcare services are expected to further accelerate the adoption of telehealth and telemedicine solutions through 2031.

The breakdown of primary participants is as mentioned below:
- By Company Type: Tier 1 (38%), Tier 2 (33%), and Tier 3 (29%)
- By Designation: Directors (35%), Managers (40%), and Others (25%)
- By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key Players
The prominent players operating in the telehealth and telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), Cisco Systems Inc. (US), Included Health, Inc. (Doctor on Demand, Inc.) (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), and Caregility (US), among others. These companies have adopted strategies such as strategic partnerships, collaborations, product launches, platform enhancements, investments in AI, mergers and acquisitions, and geographic expansion to strengthen their market presence in the telehealth and telemedicine market.

Research Coverage
This research report categorizes the telehealth and telemedicine market by component {hardware [telehealth kits, carts, and stations; patient monitoring devices (cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, and other monitoring devices)], software [modality (EHR-centric and non-EHR-centric), integration type (integrated software and standalone software), type (remote patient monitoring, virtual care platforms (real-time interaction, store & forward), video conferencing platforms, virtual sitting & nursing), deployment (on-premise model and cloud-based model), and services], function [clinical care management (including teleconsultation & follow-up), preventive care management, diagnostics & treatment, remote patient monitoring/patient monitoring, rehabilitation & recovery, administrative, analytics & reporting, patient engagement, other functions (clinical trials, education, training, and others)], application [primary care, specialty care (teleradiology, telecardiology, teleneurology, diabetes, respiratory disorders, hypertension, teledermatology, telestroke, telepsychiatry, and other specialty care applications), teleICU, virtual sitting & nursing, and other applications], age group (pediatrics, adults, and geriatrics), end user [healthcare providers (hospitals, ambulatory surgical centers, long-term care & assisted living facilities, home healthcare, and other healthcare providers), healthcare payers (public payers and private payers), patients, pharmaceutical & biotechnology companies, medtech companies, and other end users], and region. The report covers detailed information on major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of key industry players provides insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth and telemedicine market. This report covers a competitive analysis of upcoming startups in the telehealth and telemedicine market ecosystem.

Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain greater market share. Firms that purchase the report can use one or more of the following strategies to strengthen their market position.

This report provides insights on:
- Analysis of key drivers (expansion of remote patient monitoring (RPM) systems), restraints (high investment costs and lack of IT expertise), opportunities (growing use of wearables, apps, and sensors for virtual care), and challenges (data security concerns) influencing the growth of the telehealth and telemedicine market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth and telemedicine market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the telehealth and telemedicine market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth and telemedicine market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc., in the telehealth and telemedicine market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 TELEHEALTH 40
1.2.2 TELEMEDICINE 40
1.3 STUDY SCOPE 41
1.3.1 MARKETS COVERED & REGIONAL SCOPE 41
1.3.2 INCLUSIONS & EXCLUSIONS 42
1.3.3 YEARS CONSIDERED 44
1.4 CURRENCY CONSIDERED 44
1.5 STAKEHOLDERS 45

2 EXECUTIVE SUMMARY 46
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 46
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 47
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 48
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 49
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 50

3 PREMIUM INSIGHTS 52
3.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 52
3.2 TELEHEALTH & TELEMEDICINE MARKET, BY END USER & REGION 53
3.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 54

4 MARKET OVERVIEW 55
4.1 INTRODUCTION 55
4.2 MARKET DYNAMICS 55
4.2.1 DRIVERS 56
4.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure 56
4.2.1.2 Rising prevalence of chronic diseases 56
4.2.1.3 Demonstrated time and cost savings 57
4.2.1.4 Advancements in telecommunication technologies 58
4.2.1.5 Shortage of skilled healthcare professionals 58
4.2.1.6 Increased government support and favorable regulatory policies 58
4.2.1.7 Expansion of remote patient monitoring systems 59
4.2.2 RESTRAINTS 60
4.2.2.1 High investment costs for B2B models and lack of IT expertise 60
4.2.2.2 State-to-state and inter-country regulatory variations 61
4.2.2.3 Behavioral reluctance to adopt new technologies 62
4.2.2.4 Rise in fraud and abuse in healthcare systems 62
4.2.2.5 Adherence to patient privacy, confidentiality, medical ethics 63
4.2.3 OPPORTUNITIES 63
4.2.3.1 Growing use of wearables, applications, and sensors for virtual care 63
4.2.3.2 Emergence of AI and ML 63
4.2.3.3 Increasing shift toward outpatient care models 64
4.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics 65
4.2.3.5 Expansion of hospital-at-home (HaH) initiatives 65
4.2.3.6 Demand for electronic medical record-based telehealth services 65
4.2.3.7 Rising incidence of mental illnesses and growing focus on emotional well-being 66
4.2.4 CHALLENGES 66
4.2.4.1 Data security and confidentiality concerns 66
4.2.4.2 Limited data accessibility 70
4.2.4.3 Inability to maintain patient hygiene and cleanliness standards 70
4.3 UNMET NEEDS AND WHITE SPACES 70
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 71
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 72

5 INDUSTRY TRENDS 73
5.1 PORTER’S FIVE FORCES ANALYSIS 73
5.1.1 THREAT OF NEW ENTRANTS 74
5.1.2 THREAT OF SUBSTITUTES 74
5.1.3 BARGAINING POWER OF BUYERS 74
5.1.4 BARGAINING POWER OF SUPPLIERS 75
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.2 MACROECONOMIC INDICATORS 75
5.2.1 INTRODUCTION 75
5.3 VALUE CHAIN ANALYSIS 76
5.4 ECOSYSTEM ANALYSIS 78
5.5 PRICING ANALYSIS 80
5.5.1 INDICATIVE PRICE FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2026 81
5.5.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2026 82
5.6 KEY CONFERENCES & EVENTS, 2026–2027 82
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 83
5.8 INVESTMENT & FUNDING SCENARIO 84
5.9 CASE STUDY ANALYSIS 86
5.10 TARIFF AND REGULATORY ANALYSIS 88
5.10.1 TARIFF DATA ANALYSIS 88
5.10.1.1 Tariff data for HS code 9018 88
5.10.1.2 Tariff data for HS code 9021 89
5.10.1.3 Tariff data for HS code 9022 90

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 91
6.1 INDUSTRY TRENDS 91
6.2 KEY EMERGING TECHNOLOGIES 95
6.2.1 VIDEO CONFERENCING AND REAL-TIME COMMUNICATION PLATFORMS 95
6.2.2 AI AND ML 95
6.2.3 VIRTUAL ASSISTANTS AND CHATBOTS 96
6.2.4 VOICE RECOGNITION AND NATURAL LANGUAGE PROCESSING (NLP) 96
6.2.5 EHR INTEGRATION 96
6.2.6 REMOTE PATIENT MONITORING SYSTEMS 96
6.3 COMPLEMENTARY TECHNOLOGIES 97
6.3.1 EDGE COMPUTING 97
6.3.2 CLOUD COMPUTING 97
6.3.3 MOBILE HEALTH (MHEALTH) APPLICATIONS 97
6.3.4 WEARABLE DEVICES, SENSORS, AND IOT 97
6.4 ADJACENT TECHNOLOGIES 98
6.4.1 DIGITAL THERAPEUTICS 98
6.4.2 BLOCKCHAIN TECHNOLOGY 98
6.4.3 AUGMENTED REALITY AND VIRTUAL REALITY 98
6.5 TECHNOLOGY / PRODUCT ROADMAP 99
6.6 PATENT ANALYSIS 100
6.6.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE 100
6.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 100
6.7 FUTURE APPLICATIONS 103
6.7.1 REMOTE PATIENT MONITORING AND CHRONIC DISEASE MANAGEMENT 103
6.7.2 AI-ENABLED PERSONALIZED HEALTHCARE 104
6.7.3 VIRTUAL HOSPITALS AND HOSPITAL-AT-HOME CARE 104
6.8 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 104
6.8.1 KEY USE CASES 105
6.8.2 MAJOR CASE STUDIES 106
6.8.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 108
6.8.3.1 Healthcare IT and EHR systems 108
6.8.3.2 Pharmaceuticals & drug discovery 108
6.8.3.3 Mental health tech 109
6.8.3.4 Healthcare analytics and insights 109
6.8.4 USER READINESS & IMPACT ASSESSMENT 109
6.8.4.1 User readiness 109
6.8.4.1.1 User A: Hospitals 109
6.8.4.1.2 User B: Ambulatory surgery centers 109
6.8.4.2 Impact assessment 110
6.8.4.2.1 User A: Hospitals 110
6.8.4.2.2 USER B: Ambulatory surgery centers 110

7 REGULATORY LANDSCAPE 111
7.1 REGIONAL REGULATIONS AND COMPLIANCE 111
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.2 REGULATORY STANDARDS 113
7.1.3 REGULATORY FRAMEWORK 114
7.1.4 INDUSTRY STANDARDS 116

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 117
8.1 INTRODUCTION 117
8.2 DECISION-MAKING PROCESS 117
8.3 KEY STAKEHOLDERS & BUYING CRITERIA 118
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 118
8.3.2 KEY BUYING CRITERIA 119
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 119
8.5 UNMET NEEDS & END-USER ANALYSIS 120
8.5.1 UNMET NEEDS 120
8.5.2 END USER EXPECTATIONS 121
8.6 MARKET PROFITABILITY 122

9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP 123
9.1 INTRODUCTION 124
9.2 PEDIATRICS 124
9.2.1 EXPANDING ACCESS AND CARE THROUGH GROWTH OF PEDIATRIC TELEHEALTH ACROSS AGE GROUPS 124
9.3 ADULTS 125
9.3.1 SHIFT IN HEALTHCARE DELIVERY PREFERENCES DRIVES SEGMENT GROWTH 125
9.4 GERIATRICS 126
9.4.1 TRANSFORMING GERIATRIC CARE: RISE OF TELEHEALTH FOR ELDERLY PATIENTS 126

10 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 128
10.1 INTRODUCTION 129
10.2 PRIMARY CARE 129
10.2.1 ANALYZING THE TRANSFORMATION OF PRIMARY CARE THROUGH TELEHEALTH INNOVATIONS 129
10.3 SPECIALTY CARE 130
10.3.1 SPECIALTY TELEHEALTH EXPANDS ACCESS TO EXPERT MEDICAL CARE 130
10.3.2 TELERADIOLOGY 132
10.3.2.1 Teleradiology transforms healthcare with faster diagnoses and greater accessibility 132
10.3.3 TELECARDIOLOGY 133
10.3.3.1 Revolutionizing cardiac care with telecardiology to expand access and efficiency 133
10.3.4 TELENEUROLOGY 134
10.3.4.1 Use of AI and cloud-based monitoring drives market 134
10.3.5 DIABETES 135
10.3.5.1 Driving growth in diabetes specialty care through telemedicine 135
10.3.6 RESPIRATORY DISORDERS (COPD, ASTHMA, AND OTHERS) 136
10.3.6.1 Driving growth in respiratory disorder management through telemedicine 136
10.3.7 HYPERTENSION 137
10.3.7.1 Transforming hypertension management with telehealth technologies 137
10.3.8 TELEDERMATOLOGY 138
10.3.8.1 Rising prevalence of skin diseases and growing use of HD cameras for skin diagnosis to drive market 138
10.3.9 TELESTROKE 139
10.3.9.1 Rising incidence of stroke and increasing geriatric population to drive market 139
10.3.10 TELEPSYCHIATRY (MENTAL HEALTH) 140
10.3.10.1 Shortage of mental health practitioners and favorable reimbursement scenario to drive market 140
10.3.11 OTHERS 141
10.3.11.1 Expanding telehealth solutions across diverse specialties: from oncology to ophthalmology 141
10.4 TELEICU 142
10.4.1 INCREASING NUMBER OF PATIENTS IN EMERGENCY DEPARTMENTS AND STAFF SHORTAGE IN RURAL AREAS TO DRIVE MARKET 142
10.5 VIRTUAL SITTING & NURSING 143
10.5.1 DRIVING GROWTH IN VIRTUAL SITTING AND NURSING THROUGH TELEHEALTH & TELEMEDICINE 143
10.6 OTHER APPLICATIONS 144
10.6.1 EXPANDING TELEHEALTH GROWTH ACROSS DIVERSE APPLICATIONS:
CLINICAL TRIALS, URGENT CARE, AND WELLNESS 144

11 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 145
11.1 INTRODUCTION 146
11.1.1 HARDWARE 146
11.1.1.1 Transforming telehealth and telemedicine with advanced hardware solutions 146
11.1.2 TELEHEALTH KITS, CARTS, AND STATIONS 147
11.1.2.1 Empowering remote care with telehealth kits, carts, and stations 147
11.1.3 PATIENT MONITORING DEVICES 148
11.1.3.1 Empowering telehealth with advanced patient monitoring solutions 148
11.1.3.2 Cardiac monitoring devices 149
11.1.3.2.1 Empowering remote cardiac care through advanced monitoring solutions 149
11.1.3.3 Neurological monitoring devices 149
11.1.3.3.1 Transforming neurocare with advanced telemedicine solutions 149
11.1.3.4 Respiratory monitoring devices 150
11.1.3.4.1 Transforming respiratory care with remote monitoring solutions 150
11.1.3.5 Blood glucose monitoring devices 151
11.1.3.5.1 Revolutionizing diabetes management through remote monitoring 151
11.1.3.6 Fetal & neonatal monitoring devices 151
11.1.3.6.1 Enhancing maternal and infant care with remote monitoring solutions 151
11.1.3.7 Weight monitoring devices 152
11.1.3.7.1 Supporting weight management through remote monitoring technologies 152
11.1.3.8 Multiparameter monitoring devices 153
11.1.3.8.1 Elevating remote care with multiparameter monitoring devices 153
11.1.3.9 Pulse oximeter devices 153
11.1.3.9.1 Improved patient outcomes and reduced costs drive market 153
11.1.3.10 Other monitoring devices 154
11.1.3.10.1 Expanding telehealth capabilities with diverse monitoring devices 154
11.2 SOFTWARE 155
11.2.1 DRIVING TELEHEALTH INNOVATION THROUGH ADVANCED SOFTWARE SOLUTIONS 155
11.2.2 BY MODALITY 155
11.2.2.1 Leveraging EHR-centric and non-EHR-centric software modalities in telehealth 155
11.2.2.2 EHR Centric 156
11.2.2.2.1 Enhancing telehealth with EHR-centric software solutions 156
11.2.2.3 Non-HER Centric 157
11.2.2.3.1 Leveraging non-EHR centric software in telehealth and telemedicine 157
11.2.3 BY INTEGRATION TYPE 157
11.2.3.1 Maximizing telemedicine efficiency with integrated and standalone software solutions 157
11.2.3.2 Integrated Software 158
11.2.3.2.1 Advancements in technology to boost segment 158
11.2.3.3 Standalone software 159
11.2.3.3.1 Additional features that offer flexibility drive market 159
11.2.4 TYPE 159
11.2.4.1 Transforming telehealth with remote patient monitoring and virtual care platforms 159
11.2.4.2 Remote patient monitoring 160
11.2.4.2.1 Convenience of tracking patient vitals from different places to drive segment 160
11.2.4.3 Virtual care platform 161
11.2.4.3.1 Driving digital transformation in telemedicine through virtual care platforms 161
11.2.4.3.2 Real-time interaction 162
11.2.4.3.2.1 Synchronous nature and potential for better healthcare access to drive segment 162
11.2.4.3.3 Store and forward 163
11.2.4.3.3.1 Easy monitoring of vital signs for long-term chronic care without physical presence to drive segment 163
11.2.4.4 Video conferencing platforms 163
11.2.4.4.1 Revolutionizing Remote Care Delivery with Video Conferencing Platforms 163
11.2.4.5 Virtual sitting & nursing 164
11.2.4.5.1 Proactive patient monitoring to improve outcomes and reduce costs 164
11.2.5 BY DEPLOYMENT 165
11.2.5.1 Transforming telehealth with remote patient monitoring and virtual care platforms 165
11.2.5.2 On-premise model 166
11.2.5.2.1 Enhanced control of software and easy reuse of existing infrastructure to drive market 166
11.2.5.3 Cloud-based model 167
11.2.5.3.1 Cloud-based model segment to dominate market during forecast period 167
11.2.6 SERVICES 168
11.2.6.1 Key role in enhancing telehealth and telemedicine to boost segment 168

12 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 169
12.1 INTRODUCTION 170
12.2 HEALTHCARE PROVIDERS 170
12.2.1 HOSPITALS 172
12.2.1.1 Growing incidence of chronic diseases and rising demand for high-quality care to drive segment 172
12.2.2 AMBULATORY SURGICAL CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 173
12.2.2.1 Increasing preference for same-day surgeries and demand for cost-effective care to drive adoption of telehealth and telemedicine 173
12.2.3 LONG-TERM CARE AND ASSISTED LIVING FACILITIES 174
12.2.3.1 Increasing geriatric population and rising need for prolonged treatment for chronic diseases to drive segment 174
12.2.4 HOME HEALTHCARE 175
12.2.4.1 Rising aging population and growing focus on patient-centered care to propel home healthcare segment 175
12.2.5 OTHER HEALTHCARE PROVIDERS 175
12.2.5.1 Advancements in technology and increasing need for comprehensive care to drive adoption across specialized centers 175
12.3 HEALTHCARE PAYERS 176
12.3.1 PUBLIC PAYERS 177
12.3.1.1 Increasing investments by public payers to drive segment 177
12.3.2 PRIVATE PAYERS 178
12.3.2.1 Expansion of telehealth services to mental health and substance usage to drive segment 178
12.4 PATIENTS 179
12.4.1 RISING PREVALENCE OF CHRONIC DISEASES AND EMERGENCE OF ADVANCED WEARABLE MONITORS TO DRIVE MARKET 179
12.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 180
12.5.1 ADVANCEMENTS IN TELEMEDICINE PROVIDE PHARMACEUTICAL AND BIOTECH COMPANIES WITH NEW AVENUES FOR DRUG DEVELOPMENT AND MONITORING 180
12.6 MEDTECH COMPANIES 181
12.6.1 ADVANCING REMOTE CARE THROUGH INNOVATIVE TELEHEALTH SOLUTIONS DRIVES GROWTH FOR MEDTECH COMPANIES 181
12.7 OTHER END USERS 182

13 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 183
13.1 INTRODUCTION 184
13.2 CLINICAL CARE MANAGEMENT 185
13.2.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 185
13.3 PREVENTIVE CARE MANAGEMENT 186
13.3.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 186
13.4 DIAGNOSTICS & TREATMENT 187
13.4.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 187
13.5 REMOTE PATIENT MONITORING/PATIENT MONITORING 188
13.5.1 SEAMLESS PATIENT CARE THROUGH REMOTE MONITORING TECHNOLOGIES 188
13.6 REHABILITATION & RECOVERY 189
13.6.1 REDEFINING REMOTE RECOVERY WITH TELEREHABILITATION IN THE DIGITAL AGE 189
13.7 ADMINISTRATIVE 190
13.7.1 OPTIMIZING ADMINISTRATIVE SEGMENTS IN TELEHEALTH FOR ENHANCED WORKFLOW EFFICIENCY 190
13.8 ANALYTICS & REPORTING 191
13.8.1 SEAMLESS PATIENT CARE THROUGH REMOTE MONITORING TECHNOLOGIES 191
13.9 PATIENT ENGAGEMENT 192
13.9.1 EMPOWERING PATIENTS THROUGH ENGAGEMENT IN TELEHEALTH TRANSFORMATION 192
13.10 OTHER FUNCTIONS 193
13.10.1 EDUCATION & TRAINING PRACTICES TO LEAD TO TELEHEALTH GROWTH 193

14 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 194
14.1 INTRODUCTION 195
14.2 NORTH AMERICA 195
14.2.1 US 203
14.2.1.1 Legislative extensions as a driving force in expanding telehealth and telemedicine access to drive market. 203
14.2.2 CANADA 210
14.2.2.1 Government investments and digital integration to fuel the market 210
14.3 EUROPE 216
14.3.1 GERMANY 223
14.3.1.1 Key legislative reforms driving the digital transformation of healthcare in Germany 223
14.3.2 UK 229
14.3.2.1 Accelerating healthcare access and efficiency through digital transformation is driving the market 229
14.3.3 FRANCE 236
14.3.3.1 Strategic investments and policy reforms are driving the market 236
14.3.4 ITALY 242
14.3.4.1 Strategic government investments fuel growth in Italy's telehealth market. 242
14.3.5 SPAIN 249
14.3.5.1 Surging investment and increasing adoption of wearable technology is driving the market 249
14.3.6 REST OF EUROPE 256
14.4 ASIA PACIFIC 262
14.4.1 CHINA 270
14.4.1.1 Advancing digital health infrastructure to drive market in China 270
14.4.2 JAPAN 276
14.4.2.1 Government reforms and technological advancements driving growth in Japan's telemedicine market. 276
14.4.3 INDIA 283
14.4.3.1 Government initiatives for digitalization is driving the market in India 283
14.4.4 AUSTRALIA 289
14.4.4.1 Government investment in rural aged care is driving the market in Australia 289
14.4.5 REST OF ASIA PACIFIC 296
14.5 LATIN AMERICA 302
14.5.1 EXPANDING ACCESS THROUGH DIGITAL INNOVATION 302
14.5.2 BRAZIL 309
14.5.2.1 Bridging gaps with telemedicine 309
14.5.3 MEXICO 316
14.5.3.1 Mexico’s digital healthcare expansion: telehealth & telemedicine advancements 316
14.5.4 REST OF LATIN AMERICA 323
14.6 MIDDLE EAST & AFRICA 329
14.6.1 GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH FOR TELEHEALTH & TELEMEDICINE SOLUTION 329
14.6.2 GCC COUNTRIES 336
14.6.2.1 Shortage of healthcare workforce to support market growth 336
14.6.3 REST OF MIDDLE EAST & AFRICA 342
14.6.3.1 Improvement in healthcare infrastructure to support telemedicine and telehealth platforms 342

15 COMPETITIVE LANDSCAPE 350
15.1 OVERVIEW 350
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 350
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH AND TELEMEDICINE MARKET 351
15.3 REVENUE ANALYSIS, 2021–2025 355
15.4 MARKET SHARE ANALYSIS, 2025 356
15.5 COMPANY VALUATION AND FINANCIAL METRICS 359
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 360
15.6.1 STARS 360
15.6.2 EMERGING LEADERS 360
15.6.3 PERVASIVE PLAYERS 360
15.6.4 PARTICIPANTS 360
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 362
15.6.5.1 Company footprint 362
15.6.5.2 Region footprint 363
15.6.5.3 Function footprint 364
15.6.5.4 Application footprint 365
15.6.5.5 Component footprint 366
15.6.5.6 End user footprint 367
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 368
15.7.1 PROGRESSIVE COMPANIES 368
15.7.2 RESPONSIVE COMPANIES 368
15.7.3 DYNAMIC COMPANIES 368
15.7.4 STARTING BLOCKS 368
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 370
15.7.5.1 Detailed list of key startups/SMEs 370
15.7.5.2 Competitive benchmarking of key startups/SMEs 370
15.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS 371
15.9 COMPETITIVE SCENARIO 372
15.9.1 PRODUCT LAUNCHES & APPROVALS 372
15.9.2 DEALS 373
15.9.3 EXPANSIONS 374
15.9.4 OTHER DEVELOPMENTS 375

16 COMPANY PROFILES 376
16.1 KEY PLAYERS 376
16.1.1 MEDTRONIC 376
16.1.1.1 Business overview 376
16.1.1.2 Products/Services/Solutions offered 378
16.1.1.3 Recent developments 380
16.1.1.3.1 Product launches and enhancements 380
16.1.1.3.2 Deals 380
16.1.1.4 MnM view 381
16.1.1.4.1 Right to win 381
16.1.1.4.2 Strategic choices 381
16.1.1.4.3 Weaknesses & competitive threats 381
16.1.2 TELADOC HEALTH, INC. 382
16.1.2.1 Business overview 382
16.1.2.2 Products/Services/Solutions offered 384
16.1.2.3 Recent developments 385
16.1.2.3.1 Product launches and enhancements 385
16.1.2.3.2 Deals 386
16.1.2.4 MnM view 387
16.1.2.4.1 Right to win 387
16.1.2.4.2 Strategic choices 387
16.1.2.4.3 Weaknesses & competitive threats 387
16.1.3 CISCO SYSTEMS, INC. 388
16.1.3.1 Business overview 388
16.1.3.2 Products/Services/Solutions offered 390
16.1.4 DEALS 391
16.1.4.1 MnM view 391
16.1.4.1.1 Right to win 391
16.1.4.1.2 Strategic choices 391
16.1.4.1.3 Weaknesses & competitive threats 391
16.1.5 KONINKLIJKE PHILIPS N.V. 392
16.1.5.1 Business overview 392
16.1.5.2 Products/Services/Solutions offered 394
16.1.5.3 Recent developments 396
16.1.5.3.1 Product launches & approvals 396
16.1.5.3.2 Deals 397
16.1.5.4 MnM view 398
16.1.5.4.1 Right to win 398
16.1.5.4.2 Strategic choices 398
16.1.5.4.3 Weaknesses & competitive threats 398
16.1.6 ZOOM COMMUNICATIONS, INC. 399
16.1.6.1 Business overview 399
16.1.6.2 Products/Services/Solutions offered 400
16.1.6.3 Recent developments 400
16.1.6.3.1 Deals 400
16.1.6.4 MnM view 401
16.1.6.4.1 Right to win 401
16.1.6.4.2 Strategic choices 401
16.1.6.4.3 Weaknesses & competitive threats 402
16.1.7 GE HEALTHCARE 403
16.1.7.1 Business overview 403
16.1.7.2 Products/Services/Solutions offered 405
16.1.7.3 Recent developments 406
16.1.7.3.1 Product launches 406
16.1.7.3.2 Deals 406
16.1.7.3.3 Other developments 407
16.1.8 EPIC SYSTEMS CORPORATION 408
16.1.8.1 Business overview 408
16.1.8.2 Products/Services/Solutions offered 408
16.1.8.3 Recent developments 410
16.1.8.3.1 Product launches and enhancements 410
16.1.8.3.2 Deals 411
16.1.9 ORACLE 412
16.1.9.1 Business overview 412
16.1.9.2 Products/Services/Solutions offered 414
16.1.9.3 Recent developments 415
16.1.9.3.1 Product launches 415
16.1.9.3.2 Deals 416
16.1.10 DOXIMITY, INC. 418
16.1.10.1 Business overview 418
16.1.10.2 Products/Services/Solutions offered 419
16.1.10.3 Recent developments 420
16.1.10.3.1 Product enhancements 420
16.1.10.3.2 Deals 420
16.1.10.3.3 Other developments 421
16.1.11 AMERICAN WELL 422
16.1.11.1 Business overview 422
16.1.11.2 Products/Services/Solutions offered 423
16.1.11.3 Recent developments 424
16.1.11.3.1 Product launches 424
16.1.11.3.2 Deals 424
16.1.11.3.3 Other developments 425
16.1.12 SIEMENS HEALTHINEERS AG 426
16.1.12.1 Business overview 426
16.1.12.2 Products/Services/Solutions offered 428
16.1.12.3 Recent developments 429
16.1.12.3.1 Product launches 429
16.1.12.3.2 Deals 429
16.1.13 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.) 431
16.1.13.1 Business overview 431
16.1.13.2 Products/Services/Solutions offered 432
16.1.13.3 Recent developments 432
16.1.13.3.1 DEALS 432
16.1.13.3.2 Other developments 434
16.1.14 AMC HEALTH 435
16.1.14.1 Business overview 435
16.1.14.2 Products/Services/Solutions offered 435
16.1.14.3 Recent developments 436
16.1.14.3.1 Deals 436
16.1.15 TELESPECIALISTS 437
16.1.15.1 Business overview 437
16.1.15.2 Products/Services/Solutions offered 437
16.1.15.3 Recent developments 438
16.1.15.3.1 Product launches 438
16.1.15.3.2 Other developments 438
16.1.16 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 439
16.1.16.1 Business overview 439
16.1.16.2 Products/Services/Solutions offered 440
16.1.16.3 Recent developments 440
16.1.16.3.1 Product launches 440
16.1.16.3.2 Deals 440
16.1.16.3.3 Expansions 441
16.1.16.3.4 Other developments 441
16.1.17 CAREGILITY 442
16.1.17.1 Business overview 442
16.1.17.2 Products/Services offered 442
16.1.17.3 Recent developments 443
16.1.17.3.1 Deals 443
16.1.18 CVS HEALTH 444
16.1.18.1 Business overview 444
16.1.18.2 Products/Services/Solutions offered 445
16.1.18.3 Recent developments 445
16.1.18.3.1 Product launches 445
16.1.18.3.2 Deals 446
16.1.19 EVERNORTH HEALTH, INC. 447
16.1.19.1 Products/Services/Solutions offered 449
16.1.19.2 Recent developments 449
16.1.19.2.1 Deals 449
16.1.20 ELATION 450
16.1.20.1 Business overview 450
16.1.20.2 Products/Services/Solutions offered 450
16.1.20.3 Recent developments 450
16.1.20.3.1 Deals 450
16.1.21 IRON BOW TECHNOLOGIES 451
16.1.21.1 Business overview 451
16.1.21.2 Products/Services/Solutions offered 452
16.2 OTHER PLAYERS 453
16.2.1 TIMEDOC, INC. 453
16.2.2 CEREBRAL INC. 454
16.2.3 KINDBODY 455
16.2.4 TRANSCARENT 456
16.2.5 CARESIMPLE INC. 457

17 RESEARCH METHODOLOGY 458
17.1 RESEARCH DATA 458
17.1.1 SECONDARY DATA 459
17.1.1.1 Key data from secondary sources 460
17.1.2 PRIMARY DATA 460
17.1.2.1 Key data from primary sources 461
17.1.2.2 Insights from primary experts 462
17.2 MARKET SIZE ESTIMATION 463
17.3 DATA TRIANGULATION 467
17.4 MARKET SHARE ESTIMATION 468
17.5 RESEARCH ASSUMPTIONS 468
17.6 LIMITATIONS 468
17.6.1 METHODOLOGY-RELATED LIMITATIONS 468
17.6.2 SCOPE-RELATED LIMITATIONS 468
17.7 RISK ASSESSMENT 469

18 APPENDIX 470
18.1 DISCUSSION GUIDE 470
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 477
18.3 CUSTOMIZATION OPTIONS 479
18.4 RELATED REPORTS 479
18.5 AUTHOR DETAILS 480

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION & REGIONAL SCOPE 41.
FIGURE 2 MARKET SCENARIO 46.
FIGURE 3 GLOBAL TELEHEALTH AND TELEMEDICINE MARKET, 2024–2031 47.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH AND.
TELEMEDICINE MARKET, 2024–2026 47.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF TELEHEALTH AND TELEMEDICINE MARKET 48.
FIGURE 6 HIGH-GROWTH SEGMENTS IN TELEHEALTH AND TELEMEDICINE MARKET, 2026–2031 49.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN TELEHEALTH AND TELEMEDICINE MARKET DURING FORECAST PERIOD 50.
FIGURE 8 NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE EXPENSES.
TO DRIVE GROWTH IN TELEHEALTH & TELEMEDICINE MARKET 52.
FIGURE 9 HEALTHCARE PROVIDERS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 53.
FIGURE 10 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54.
FIGURE 11 TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,.
AND CHALLENGES 55.
FIGURE 12 US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS,.
BY STATE (SEPTEMBER 2024) 64.
FIGURE 13 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 67.
FIGURE 14 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 67.
FIGURE 15 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 68.
FIGURE 16 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 73.
FIGURE 17 TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS 78.
FIGURE 18 TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS 79.
FIGURE 19 TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 84.
FIGURE 20 FUNDING AND DEALS IN TELEHEALTH & TELEMEDICINE MARKET 85.
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN TELEHEALTH & TELEMEDICINE, 2015–2026 100.
FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015–SEPTEMBER 2026) 101.
FIGURE 23 POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 105.
FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 118.
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 119.
FIGURE 26 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 196.
FIGURE 27 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 263.
FIGURE 28 TELEHEALTH AND TELEMEDICINE MARKET: REVENUE ANALYSIS OF.
KEY PLAYERS, 2021–2025 (USD MILLION) 355.
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN TELEHEALTH AND TELEMEDICINE MARKET, 2025 356.
FIGURE 30 EV/EBITDA OF KEY VENDORS 359.
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 359.
FIGURE 32 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX.
(KEY PLAYERS), 2025 361.
FIGURE 33 TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 362.
FIGURE 34 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 369.
FIGURE 35 TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 371.
FIGURE 36 MEDTRONIC: COMPANY SNAPSHOT 377.
FIGURE 37 TELADOC HEALTH, INC.: COMPANY SNAPSHOT 383.
FIGURE 38 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT 389.
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 393.
FIGURE 40 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT 399.
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT 404.
FIGURE 42 ORACLE: COMPANY SNAPSHOT 413.
FIGURE 43 DOXIMITY, INC.: COMPANY SNAPSHOT 418.
FIGURE 44 AMERICAN WELL: COMPANY SNAPSHOT 422.
FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 427.
FIGURE 46 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): COMPANY SNAPSHOT 439.
FIGURE 47 CVS HEALTH: COMPANY SNAPSHOT 444.
FIGURE 48 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT 448.
FIGURE 49 RESEARCH DESIGN 458.
FIGURE 50 PRIMARY SOURCES 460.
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):.
BY COMPANY TYPE, DESIGNATION, AND REGION 462.
FIGURE 52 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 463.
FIGURE 53 TOP-DOWN APPROACH 464.
FIGURE 54 CAGR PROJECTIONS, 2026–2031 465.
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 466.
FIGURE 56 DATA TRIANGULATION 467.
TABLE 1 CHRONIC DISEASES AND RELATED COST BURDEN IN US 57.
TABLE 2 RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS,.
JANUARY 2023–JANUARY 2026 59.
TABLE 3 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 61.
TABLE 4 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024 68.
TABLE 5 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 74.
TABLE 6 TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 79.
TABLE 7 COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD) 80.
TABLE 8 INDICATIVE PRICE FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,.
BY COMPONENT, 2026 81.
TABLE 9 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS 81.
TABLE 10 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2026 82.
TABLE 11 TELEHEALTH & TELEMEDICINE MARKET: KEY CONFERENCES & EVENTS, 2026–2027 83.
TABLE 12 CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS 86.
TABLE 13 CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES 86.
TABLE 14 CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEICU AND TELEHEALTH FOR SEAMLESS TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS 87.
TABLE 15 AVERAGE TARIFF FOR HS CODE 9018, 2025 88.
TABLE 16 AVERAGE TARIFF FOR HS CODE 9021, 2025 89.
TABLE 17 AVERAGE TARIFF FOR HS CODE 9022, 2025 90.
TABLE 18 INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET 91.
TABLE 19 OVERVIEW OF TELEHEALTH USE CASES 94.
TABLE 20 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR TELEHEALTH & TELEHEALTH 100.
TABLE 21 TELEHEALTH AND TELEMEDICINE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 102.
TABLE 22 AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY 106.
TABLE 23 AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL HEALTH AND.
CHRONIC DISEASE MANAGEMENT 107.
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 111.
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112.
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 113.
TABLE 27 TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS 113.
TABLE 28 REGULATORY REQUIREMENTS IN NORTH AMERICA 114.
TABLE 29 REGULATORY REQUIREMENTS IN EUROPE 114.
TABLE 30 REGULATORY REQUIREMENTS IN ASIA PACIFIC 115.
TABLE 31 REGULATORY REQUIREMENTS IN LATIN AMERICA 116.
TABLE 32 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 116.
TABLE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 118.
TABLE 34 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 119.
TABLE 35 UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET 120.
TABLE 36 END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET 121.
TABLE 37 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 124.
TABLE 38 TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS,.
BY REGION, 2024–2031 (USD MILLION) 125.
TABLE 39 TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS,.
BY REGION, 2024–2031 (USD MILLION) 126.
TABLE 40 TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS,.
BY REGION, 2024–2031 (USD MILLION) 127.
TABLE 41 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129.
TABLE 42 TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE,.
BY REGION, 2024–2031 (USD MILLION) 130.
TABLE 43 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 131.
TABLE 44 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY REGION, 2024–2031 (USD MILLION) 132.
TABLE 45 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY,.
BY REGION, 2024–2031 (USD MILLION) 133.
TABLE 46 TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY,.
BY REGION, 2024–2031 (USD MILLION) 134.
TABLE 47 TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY,.
BY REGION, 2024–2031 (USD MILLION) 135.
TABLE 48 TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES,.
BY REGION 2024–2031 (USD MILLION) 136.
TABLE 49 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS,.
BY REGION, 2024–2031 (USD MILLION) 137.
TABLE 50 TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION,.
BY REGION, 2024–2031 (USD MILLION) 137.
TABLE 51 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY,.
BY REGION, 2024–2031 (USD MILLION) 138.
TABLE 52 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE,.
BY REGION, 2024–2031 (USD MILLION) 139.
TABLE 53 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY (MENTAL HEALTH),.
BY REGION, 2024–2031 (USD MILLION) 140.
TABLE 54 TELEHEALTH & TELEMEDICINE MARKET FOR OTHERS,.
BY REGION, 2024–2031 (USD MILLION) 141.
TABLE 55 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU,.
BY REGION, 2024–2031 (USD MILLION) 142.
TABLE 56 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING,.
BY REGION, 2024–2031 (USD MILLION) 143.
TABLE 57 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 144.
TABLE 58 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 146.
TABLE 59 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY REGION, 2024–2031 (USD MILLION) 147.
TABLE 60 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 147.
TABLE 61 TELEHEALTH & TELEMEDICINE MARKET FOR TELEHEALTH KITS, CARTS,.
AND STATIONS, BY REGION, 2024–2031 (USD MILLION) 148.
TABLE 62 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 148.
TABLE 63 TELEHEALTH & TELEMEDICINE MARKET FOR CARDIAC MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 149.
TABLE 64 TELEHEALTH & TELEMEDICINE MARKET FOR NEUROLOGICAL MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 150.
TABLE 65 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 150.
TABLE 66 TELEHEALTH & TELEMEDICINE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 151.
TABLE 67 TELEHEALTH & TELEMEDICINE MARKET FOR FETAL & NEONATAL MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 152.
TABLE 68 TELEHEALTH & TELEMEDICINE MARKET FOR WEIGHT MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 152.
TABLE 69 TELEHEALTH & TELEMEDICINE MARKET FOR MULTIPARAMETER MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 153.
TABLE 70 TELEHEALTH & TELEMEDICINE MARKET FOR PULSE OXIMETER DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 154.
TABLE 71 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER MONITORING DEVICES,.
BY REGION, 2024–2031 (USD MILLION) 154.
TABLE 72 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY REGION, 2024–2031 (USD MILLION) 155.
TABLE 73 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 156.
TABLE 74 TELEHEALTH & TELEMEDICINE MARKET FOR EHR CENTRIC MODALITIES,.
BY REGION, 2024–2031 (USD MILLION) 156.
TABLE 75 TELEHEALTH & TELEMEDICINE MARKET FOR NON-EHR CENTRIC MODALITIES,.
BY REGION, 2024–2031 (USD MILLION) 157.
TABLE 76 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 158.
TABLE 77 TELEHEALTH & TELEMEDICINE MARKET FOR INTEGRATED SOFTWARE,.
BY REGION, 2024–2031 (USD MILLION) 158.
TABLE 78 TELEHEALTH & TELEMEDICINE MARKET FOR STANDALONE SOFTWARE,.
BY REGION, 2024–2031 (USD MILLION) 159.
TABLE 79 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 160.
TABLE 80 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING,.
BY REGION, 2024–2031 (USD MILLION) 161.
TABLE 81 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE PLATFORMS,.
BY REGION, 2024–2031 (USD MILLION) 162.
TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR VIDEO CONFERENCING PLATFORMS,.
BY REGION, 2024–2031 (USD MILLION) 164.
TABLE 83 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING,.
BY REGION, 2024–2031 (USD MILLION) 165.
TABLE 84 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 166.
TABLE 85 TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE MODEL,.
BY REGION, 2024–2031 (USD MILLION) 166.
TABLE 86 TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED MODEL,.
BY REGION, 2024–2031 (USD MILLION) 167.
TABLE 87 TELEHEALTH & TELEMEDICINE MARKET FOR SERVICES,.
BY REGION, 2024–2031 (USD MILLION) 168.
TABLE 88 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 170.
TABLE 89 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 90 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY REGION, 2024–2031 (USD MILLION) 171.
TABLE 91 TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS,.
BY REGION, 2024–2031 (USD MILLION) 172.
TABLE 92 TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGICAL CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS,.
BY REGION, 2024–2031 (USD MILLION) 173.
TABLE 93 TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE AND ASSISTED LIVING FACILITIES, BY REGION, 2024–2031 (USD MILLION) 174.
TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE,.
BY REGION, 2024–2031 (USD MILLION) 175.
TABLE 95 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS,.
BY REGION, 2024–2031 (USD MILLION) 176.
TABLE 96 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 97 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY REGION, 2024–2031 (USD MILLION) 177.
TABLE 98 TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC PAYERS,.
BY REGION, 2024–2031 (USD MILLION) 178.
TABLE 99 TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE PAYERS,.
BY REGION, 2024–2031 (USD MILLION) 179.
TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS,.
BY REGION, 2024–2031 (USD MILLION) 180.
TABLE 101 TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 181.
TABLE 102 TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES,.
BY REGION, 2024–2031 (USD MILLION) 182.
TABLE 103 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS,.
BY REGION, 2024–2031 (USD MILLION) 182.
TABLE 104 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 184.
TABLE 105 TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT,.
BY REGION, 2024–2031 (USD MILLION) 185.
TABLE 106 TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT,.
BY REGION, 2024–2031 (USD MILLION) 186.
TABLE 107 TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT,.
BY REGION, 2024–2031 (USD MILLION) 187.
TABLE 108 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/PATIENT MONITORING, BY REGION, 2024–2031 (USD MILLION) 188.
TABLE 109 TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY,.
BY REGION, 2024–2031 (USD MILLION) 189.
TABLE 110 TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE,.
BY REGION, 2024–2031 (USD MILLION) 190.
TABLE 111 TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING,.
BY REGION, 2024–2031 (USD MILLION) 191.
TABLE 112 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT,.
BY REGION, 2024–2031 (USD MILLION) 192.
TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS,.
BY REGION, 2024–2031 (USD MILLION) 193.
TABLE 114 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2024–2031 (USD MILLION) 195.
TABLE 115 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 196.
TABLE 116 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY COMPONENT, 2024–2031 (USD MILLION) 197.
TABLE 117 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 197.
TABLE 118 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 119 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 198.
TABLE 120 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 199.
TABLE 121 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 199.
TABLE 122 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 200.
TABLE 123 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 201.
TABLE 124 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY AGE GROUP, 2024–2031 (USD MILLION) 201.
TABLE 125 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,.
BY END USER, 2024–2031 (USD MILLION) 202.
TABLE 126 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 127 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 128 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 204.
TABLE 129 US: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 130 US: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 131 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 205.
TABLE 132 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 206.
TABLE 133 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 206.
TABLE 134 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 206.
TABLE 135 US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 207.
TABLE 136 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 207.
TABLE 137 US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 208.
TABLE 138 US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 208.
TABLE 139 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 209.
TABLE 140 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 141 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 210.
TABLE 142 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 210.
TABLE 143 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 144 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 145 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 212.
TABLE 146 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 212.
TABLE 147 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 148 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 213.
TABLE 149 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 213.
TABLE 150 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 214.
TABLE 151 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 214.
TABLE 152 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 215.
TABLE 153 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 215.
TABLE 154 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 155 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 156 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 217.
TABLE 157 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 217.
TABLE 158 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 159 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 160 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 218.
TABLE 161 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 219.
TABLE 162 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 163 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 219.
TABLE 164 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 220.
TABLE 165 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 220.
TABLE 166 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 221.
TABLE 167 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 221.
TABLE 168 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 222.
TABLE 169 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 222.
TABLE 170 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 171 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 223.
TABLE 172 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE,.
2024–2031 (USD MILLION) 224.
TABLE 173 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 224.
TABLE 174 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 225.
TABLE 175 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 225.
TABLE 176 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 225.
TABLE 177 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 226.
TABLE 178 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 226.
TABLE 179 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 227.
TABLE 180 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 181 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 228.
TABLE 182 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 228.
TABLE 183 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 229.
TABLE 184 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 229.
TABLE 185 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 230.
TABLE 186 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 230.
TABLE 187 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 188 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY MODALITY,.
2024–2031 (USD MILLION) 231.
TABLE 189 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 232.
TABLE 190 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY TYPE,.
2024–2031 (USD MILLION) 232.
TABLE 191 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 232.
TABLE 192 UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 233.
TABLE 193 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 233.
TABLE 194 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 195 UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 234.
TABLE 196 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 235.
TABLE 197 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 198 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 236.
TABLE 199 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 236.
TABLE 200 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 201 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 202 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 238.
TABLE 203 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 238.
TABLE 204 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 205 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 239.
TABLE 206 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 239.
TABLE 207 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 240.
TABLE 208 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 240.
TABLE 209 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 241.
TABLE 210 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 241.
TABLE 211 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 242.
TABLE 212 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 242.
TABLE 213 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 243.
TABLE 214 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 243.
TABLE 215 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 216 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 244.
TABLE 217 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 245.
TABLE 218 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 219 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 245.
TABLE 220 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 246.
TABLE 221 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 246.
TABLE 222 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 247.
TABLE 223 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 247.
TABLE 224 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 248.
TABLE 225 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 226 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 227 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 249.
TABLE 228 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 229 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 230 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 251.
TABLE 231 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 251.
TABLE 232 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 251.
TABLE 233 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 252.
TABLE 234 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 252.
TABLE 235 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 253.
TABLE 236 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 237 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 254.
TABLE 238 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 254.
TABLE 239 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 255.
TABLE 240 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 255.
TABLE 241 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 256.
TABLE 242 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 243 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 257.
TABLE 244 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 257.
TABLE 245 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 258.
TABLE 246 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 258.
TABLE 247 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 258.
TABLE 248 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 259.
TABLE 249 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 259.
TABLE 250 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 260.
TABLE 251 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 260.
TABLE 252 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 261.
TABLE 253 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 261.
TABLE 254 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 262.
TABLE 255 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 263.
TABLE 256 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 264.
TABLE 257 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 264.
TABLE 258 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 265.
TABLE 259 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 265.
TABLE 260 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 266.
TABLE 261 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 266.
TABLE 262 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 266.
TABLE 263 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 267.
TABLE 264 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 267.
TABLE 265 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 268.
TABLE 266 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 268.
TABLE 267 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,.
2024–2031 (USD MILLION) 269.
TABLE 268 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 269.
TABLE 269 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,.
BY TYPE, 2024–2031 (USD MILLION) 270.
TABLE 270 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 270.
TABLE 271 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,.
BY TYPE, 2024–2031 (USD MILLION) 271.
TABLE 272 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,.
BY TYPE, 2024–2031 (USD MILLION) 271.
TABLE 273 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY MODALITY, 2024–2031 (USD MILLION) 272.
TABLE 274 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 272.
TABLE 275 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY TYPE, 2024–2031 (USD MILLION) 272.
TABLE 276 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,.
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 273.
TABLE 277 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 273.
TABLE 278 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 274.
TABLE 279 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,.
BY TYPE, 2024–2031 (USD MILLION) 274.
TABLE 280 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,.
2024–2031 (USD MILLION) 275.